Our flexible CDMO services allow us to support continuity plans and step in when pharmaceutical organizations need to ramp up production quickly without sacrificing quality.
With Nucleus RadioPharma as your dedicated partner, you can:
Our flexible CDMO services allow us to support continuity plans and step in when pharmaceutical organizations need to ramp up production quickly without sacrificing quality.
With Nucleus RadioPharma as your dedicated partner, you can:
Mitigate risks associated with supply chain disruptions, raw material shortages, or unexpected demand surges by leveraging our unique regional distribution model and interconnected resource network to reliably and rapidly produce and deliver your radiotherapies.
Our commercial-scale manufacturing facilities, which are built near prominent destination medical centers and key distribution hubs, provide the extra manufacturing and delivery redundancy you may need at any moment.
Combined with our extensive industry expertise and comprehensive offerings, you can expedite drug production, waste fewer doses, and ensure patients can access your life-saving treatments.
Production is scheduled to begin in Q4 2024 at our newly opened Rochester, MN facility.
Pharmaceutical organizations must proactively establish robust continuity plans to ensure the consistent production and delivery of their radiotherapies.
Without a proper plan—one that considers the nuances and challenges of producing and delivering radiotherapies—they risk being shut out of the market completely.